BioCentury
ARTICLE | Company News

Helsinn, Mundipharma deal

February 23, 2015 8:00 AM UTC

Helsinn granted Mundipharma exclusive rights to commercialize anamorelin in Brazil and “key markets” in the Middle East and North Africa. The once-daily small molecule ghrelin agonist has completed ...